JAZMP is Slovenia's national competent authority for medicines and publishes unusually practical pharmacovigilance information for MAHs.
Core official resources
- JAZMP pharmacovigilance — national PV framework and activities.
- Reporting suspected adverse drug reactions — reporting rules and local-literature information.
- EMA GVP.
Important national distinction
JAZMP explicitly lists Slovenian publications to be screened by MAHs for local literature and states that the obligation depends on marketing status. The authority also confirms EudraVigilance-only electronic reporting for registered MAHs under the post-2017 model.